Associated Papers
Clinical Benefit of Niraparib to TKI/mTORi-Resistance Metastatic ccRCC With BAP1-Frame Shift Mutation: Case Report and Literature Review.
Lian BJ et al.
Frontiers in Oncology, 2022
35875073 (PubMed )
Supplement: DataSheet_1.xlsx › NGS_somatic_variation_test_resu
Novel GPR34 and CCR6 mutation and distinct genetic profiles in MALT lymphomas of different sites.
Moody S et al.
Haematologica, 2018
29674500 (PubMed )
Supplement: 2018.191601.MOODY_SUPPL.pdf
Select a paper to view details